2025 Q4 -tulosraportti
43 päivää sitten
‧39 min
Tarjoustasot
Spotlight Stock Market DK
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 23.4. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 1.12.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 25.4.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·18 t sittenthen I added a bit, I even got my average down:-)
·21 t sitten16. April Curasight participates in HC Andersen Capital's seminar for institutional investors with a presentation. Has anyone here signed up for the event? https://www.linkedin.com/posts/hcandersencapital_tilmeld-dig-vores-fysiske-seminar-for-institutionelle-activity-7438133048144973825-qVPY?utm_source=share&utm_medium=member_android&rcm=ACoAAANJUfMB_b9u8SWo5Q9MrKIliuOFUOtjfsw
·2 päivää sittenI don't know about you others....but normally I would start switching to shorts around now.....if only it wasn't still so cold this year....😁·21 t sittenHi again Allani, should I buy more shares in curasight? have a nice day:-)·17 t sitten · MuokattuHahaha, hey Rollo.....well, I'd really rather not say whether you should or not. But well, the story here is a bit the same as the other one we're looking at. Possible acquisition within a short time. However, data is king. Signals from several sources point to good data. Curasight is further along (clinical and in humans). The potential/technology is the fight against 85% of all cancers. Data on the next 12 patients will come before the summer holiday, data on the first patient was very positive. Meetings with bigP etc.... My entire ASK depot is invested here. You have to decide for yourself 😉 But keep it a secret, I need to buy more when the tax money comes....🤣
·1.4.Incredible impatience - this stock has the potential to suddenly skyrocket, so those who were in on Circio from the bottom will look on enviously.
·1 päivä sittenThis is however still more expensive than Circio. Do you think this has the potential to remain more expensive, or be acquired for a larger amount than Circio?·1 päivä sitten · MuokattuHow do you calculate that Curesight is more expensive? You can't compare the price of a single share one-to-one. Look at the total valuation of the company (all shares) of the two. Curesight is "only" valued at 677 million DKK.....Circio is 2,8 billion NOK. (1,87 billion DKK) Ergo, you get a much larger proportion with one share than with one share in Circio.... But everything is about the final acquisition price, in case of a BP takeover.
·1.4.Elli Lilly just gave 51 billion for a company... That wouldn't be bad for curasight. Might not quite be up there but they are in phase 2 and phase vi 1.. and if it works.. Share price 1040.. optimistic.. but perhaps not unrealistic.. and then of course great if we can save human lives.. will be a good year
·1.4.I think we should be satisfied at a price of 100-200 and I could easily see a lower purchase price.·2 päivää sittenYes, but it is after all one of the few figures I have to work with, I can basically only hope it goes higher, but by understating my expectations, I won't be disappointed.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
43 päivää sitten
‧39 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·18 t sittenthen I added a bit, I even got my average down:-)
- ·21 t sitten16. April Curasight participates in HC Andersen Capital's seminar for institutional investors with a presentation. Has anyone here signed up for the event? https://www.linkedin.com/posts/hcandersencapital_tilmeld-dig-vores-fysiske-seminar-for-institutionelle-activity-7438133048144973825-qVPY?utm_source=share&utm_medium=member_android&rcm=ACoAAANJUfMB_b9u8SWo5Q9MrKIliuOFUOtjfsw
- ·2 päivää sittenI don't know about you others....but normally I would start switching to shorts around now.....if only it wasn't still so cold this year....😁·21 t sittenHi again Allani, should I buy more shares in curasight? have a nice day:-)·17 t sitten · MuokattuHahaha, hey Rollo.....well, I'd really rather not say whether you should or not. But well, the story here is a bit the same as the other one we're looking at. Possible acquisition within a short time. However, data is king. Signals from several sources point to good data. Curasight is further along (clinical and in humans). The potential/technology is the fight against 85% of all cancers. Data on the next 12 patients will come before the summer holiday, data on the first patient was very positive. Meetings with bigP etc.... My entire ASK depot is invested here. You have to decide for yourself 😉 But keep it a secret, I need to buy more when the tax money comes....🤣
- ·1.4.Incredible impatience - this stock has the potential to suddenly skyrocket, so those who were in on Circio from the bottom will look on enviously.·1 päivä sittenThis is however still more expensive than Circio. Do you think this has the potential to remain more expensive, or be acquired for a larger amount than Circio?·1 päivä sitten · MuokattuHow do you calculate that Curesight is more expensive? You can't compare the price of a single share one-to-one. Look at the total valuation of the company (all shares) of the two. Curesight is "only" valued at 677 million DKK.....Circio is 2,8 billion NOK. (1,87 billion DKK) Ergo, you get a much larger proportion with one share than with one share in Circio.... But everything is about the final acquisition price, in case of a BP takeover.
- ·1.4.Elli Lilly just gave 51 billion for a company... That wouldn't be bad for curasight. Might not quite be up there but they are in phase 2 and phase vi 1.. and if it works.. Share price 1040.. optimistic.. but perhaps not unrealistic.. and then of course great if we can save human lives.. will be a good year·1.4.I think we should be satisfied at a price of 100-200 and I could easily see a lower purchase price.·2 päivää sittenYes, but it is after all one of the few figures I have to work with, I can basically only hope it goes higher, but by understating my expectations, I won't be disappointed.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Spotlight Stock Market DK
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 23.4. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 1.12.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 25.4.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
2025 Q4 -tulosraportti
43 päivää sitten
‧39 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 23.4. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 1.12.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 25.4.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·18 t sittenthen I added a bit, I even got my average down:-)
- ·21 t sitten16. April Curasight participates in HC Andersen Capital's seminar for institutional investors with a presentation. Has anyone here signed up for the event? https://www.linkedin.com/posts/hcandersencapital_tilmeld-dig-vores-fysiske-seminar-for-institutionelle-activity-7438133048144973825-qVPY?utm_source=share&utm_medium=member_android&rcm=ACoAAANJUfMB_b9u8SWo5Q9MrKIliuOFUOtjfsw
- ·2 päivää sittenI don't know about you others....but normally I would start switching to shorts around now.....if only it wasn't still so cold this year....😁·21 t sittenHi again Allani, should I buy more shares in curasight? have a nice day:-)·17 t sitten · MuokattuHahaha, hey Rollo.....well, I'd really rather not say whether you should or not. But well, the story here is a bit the same as the other one we're looking at. Possible acquisition within a short time. However, data is king. Signals from several sources point to good data. Curasight is further along (clinical and in humans). The potential/technology is the fight against 85% of all cancers. Data on the next 12 patients will come before the summer holiday, data on the first patient was very positive. Meetings with bigP etc.... My entire ASK depot is invested here. You have to decide for yourself 😉 But keep it a secret, I need to buy more when the tax money comes....🤣
- ·1.4.Incredible impatience - this stock has the potential to suddenly skyrocket, so those who were in on Circio from the bottom will look on enviously.·1 päivä sittenThis is however still more expensive than Circio. Do you think this has the potential to remain more expensive, or be acquired for a larger amount than Circio?·1 päivä sitten · MuokattuHow do you calculate that Curesight is more expensive? You can't compare the price of a single share one-to-one. Look at the total valuation of the company (all shares) of the two. Curesight is "only" valued at 677 million DKK.....Circio is 2,8 billion NOK. (1,87 billion DKK) Ergo, you get a much larger proportion with one share than with one share in Circio.... But everything is about the final acquisition price, in case of a BP takeover.
- ·1.4.Elli Lilly just gave 51 billion for a company... That wouldn't be bad for curasight. Might not quite be up there but they are in phase 2 and phase vi 1.. and if it works.. Share price 1040.. optimistic.. but perhaps not unrealistic.. and then of course great if we can save human lives.. will be a good year·1.4.I think we should be satisfied at a price of 100-200 and I could easily see a lower purchase price.·2 päivää sittenYes, but it is after all one of the few figures I have to work with, I can basically only hope it goes higher, but by understating my expectations, I won't be disappointed.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Spotlight Stock Market DK
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Välittäjätilasto
Dataa ei löytynyt